Experimental group:Camrelizumab combined with chemoradiotherapy

2 trials

Sponsors

The Fourth Hospital of Hebei Medical University, Pingdingshan First People's Hospital

Conditions

cervical cancergynecological cancers

Early Phase 1

An exploratory study of Camrelizumab combined with chemoradiotherapy in the treatment of recurrent/metastatic gynecological cancers

RecruitingChiCTR2000038637

The Fourth Hospital of Hebei Medical Universitygynecological cancers

Start: 2020-10-01Updated: 2020-12-07

Phase 4

Camrelizumab combined with chemoradiotherapy for cervical cancer: a single-arm, prospective clinical study

Active, not recruitingChiCTR2100045220

Pingdingshan First People's Hospitalcervical cancer

Start: 2021-05-07Updated: 2021-11-16